Expression of Prostacyclin-Synthase in Human Breast Cancer: Negative Prognostic Factor and Protection against Cell Death <i>In Vitro</i>

<div>Relationship between PGIS expression and overall survival of 193 patients. The Kaplan-Meier survival curves shown are for subgroups with either low (IRS2) or high (IRS ≥ 3) PGIS expression among all patients under study.</div>

Mediators of Inflammation

fig2

Figure 2

Figure 2: Expression of Prostacyclin-Synthase in Human Breast Cancer: Negative Prognostic Factor and Protection against Cell Death <i>In Vitro</i> 

Mediators of Inflammation

Expression of Prostacyclin-Synthase in Human Breast Cancer: Negative Prognostic Factor and Protection against Cell Death In Vitro

Figure 2